Pro/Antioxidant State as a Potential Biomarker of Schizophrenia
To allow better diagnosis and management of psychiatric illnesses, the use of easily accessible biomarkers are proposed. Therefore, recognition of some diseases by a set of related pathogenesis biomarkers is a promising approach. The study aims to assess the usefulness of examining oxidative stress...
Main Authors: | Dariusz Juchnowicz, Michał Dzikowski, Joanna Rog, Napoleon Waszkiewicz, Kaja Hanna Karakuła, Anna Zalewska, Mateusz Maciejczyk, Hanna Karakula-Juchnowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/18/4156 |
Similar Items
-
Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia
by: Dariusz Juchnowicz, et al.
Published: (2021-11-01) -
The usefulness of a complete blood count in the prediction of the first episode of schizophrenia diagnosis and its relationship with oxidative stress.
by: Dariusz Juchnowicz, et al.
Published: (2023-01-01) -
The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia
by: Michał Dzikowski, et al.
Published: (2020-11-01) -
SKINREMS—A New Method for Assessment of the Niacin Skin Flush Test Response in Schizophrenia
by: Hanna Karakula-Juchnowicz, et al.
Published: (2020-06-01) -
The importance of blood count and oxidative stress in the drug-naïve first episode schizophrenia
by: J. Rog, et al.
Published: (2022-06-01)